Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer

Trial Details

NCT ID

NCT05914389

Phase

PHASE2

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Status

RECRUITING

Cancer Type

Colon Cancer Colorectal Cancer

Interventions

• Oxaliplatin
• Capecitabine
• Anti-PD-L1 Monoclonal Antibody
• Clostridium butyricum
• Colectomy

Locations (sample)

• Hangzhou, Zhejiang, China|30.29365,120.16142

Key Eligibility Criteria

• Age ≥18 years old and ≤75 years old.
• Pathologically diagnosed MSS or pMMR-type colon adenocarcinoma.
• The lower edge of the tumor is more than 12cm from the anus as measured by colonoscopy and the lower edge of the tumor cannot be directly palpated …
• Enhanced CT stage T3/4 or T1-4N+ without multiple primary tumors or distant metastasis.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.